Accumulation of alpha-synuclein within the liver, potential role in the clearance of brain pathology associated with Parkinson’s disease
Open accessThe DOI matches its Crossref record; 74 of the 74 references it cites were found in a registry or an index.
Abstract
Alpha-synuclein (α-syn) aggregation is the hallmark pathological lesion in brains of patients with Parkinson’s disease (PD) and related neurological disorders characterized as synucleinopathies. Accumulating evidence now indicates that α-syn deposition is also present within the gut and other peripheral organs outside the central nervous system (CNS). In the current study, we demonstrate for the first time that α-syn pathology also accumulates within the liver, the main organ responsible for substance clearance and detoxification. We further demonstrate that cultured human hepatocytes readily internalize oligomeric α-syn assemblies mediated, at least in part, by the gap junction protein connexin-32 (Cx32). Moreover, we identified a time-dependent accumulation of α-syn within the liver of three different transgenic (tg) mouse models expressing human α-syn under CNS-specific promoters, despite the lack of α-syn mRNA expression within the liver. Such a brain-to-liver transmission route could be further corroborated by detection of α-syn pathology within the liver of wild type mice one month after a single striatal α-syn injection. In contrast to the synucleinopathy models, aged mice modeling AD rarely show any amyloid-beta (Aß) deposition within the liver. In human post-mortem liver tissue, we identified cases with neuropathologically confirmed α-syn pathology containing α-syn within hepatocellular structures to a higher degree (75%) than control subjects without α-syn accumulation in the brain (57%). Our results reveal that α-syn accumulates within the liver and may be derived from the brain or other peripheral sources. Collectively, our findings indicate that the liver may play a role in the clearance and detoxification of pathological proteins in PD and related synucleinopathies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



![Fig. 4 Human α-syn inclusions within the mouse A30P liver co-localize with luminescent conjugated oligothiophenes (LCOs). A–D Human α-syn deposits immunolabeled with the 14H antibody partially co-localize with the p-FTAA and E–H HS-68 LCOs in aged A30P livers. All tissue sections were counterstained with Hoechst (blue). I Individual and J average emission spectra obtained from HS-68-positive human α-syn deposits in the aged A30P liver. K Average emission spectra obtained from HS-68-positive α-syn aggregates from human PD brains (n = 3, blue) and human MSA brains (n = 3, red). Note that the spectra in the human brains were obtained using a filter which cuts off the emitted light at 625 nm in wavelength, which was not used for this study. K Adapted from [37] with permission. © The Author(s). 2019 Open Access. Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/). Bars = 20 µm](https://figures.cochat.ai/paper-figures/759885e3baaf44d8a344d1257bff4483/accumulation-of-alpha-synuclein-within-the-liver-potential-role-in-the-clearance-figure-4.jpg)




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In PD, brain-derived α-syn accumulates in the livers of both mice and humans; thus, the liver may participate in the clearance and detoxification of α-syn,231”
From Antiageing strategy for neurodegenerative diseases: from mechanisms to clinical advances (2025) · cites this paper as [231]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mechanisms of hepatic stellate cell activation
Tsuchida, T., & Friedman, S. L. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.38 · Cited by 2,909 · cited 1×
“7M–P), specialized liver cells involved in fibrosis following liver injury [59], thus suggesting that in addition to inflammation, α-syn may promote liver toxicity.”
BackgroundLuk, K. C., Kehm, V., Carroll, J., Zhang, B., O’Brien, P., Trojanowski, J. Q., & Lee, V. M.-Y. (2012) · Science · doi:10.1126/science.1227157 · Cited by 2,563 · cited 1×
“in WT mice To further explore whether α-syn is transported from the brain to the liver, we took advantage of a widely established mouse model of PD involving α-syn injections in the brain leading to α-syn self-assembly and accumulation that is detected within the brain approximately within 20–30 days post-protein inje…”
BackgroundKim, S., Kwon, S.-H., Kam, T.-I., Panicker, N., Karuppagounder, S. S., Lee, S., Lee, J. H., Kim, W. R., Kook, M., Foss, C. A., et al. (2019) · Neuron · doi:10.1016/j.neuron.2019.05.035 · Cited by 1,397 · cited 2×
“Furthermore, multiple studies have shown the presence and progressive accumulation of α-syn within the vagal nerve leading to the dorsal motor nucleus of the vague following injections in the gut [27].”
BackgroundInfluentialSingle App knock-in mouse models of Alzheimer’s disease
Saito, T., Matsuba, Y., Mihira, N., Takano, J., Nilsson, P., Itohara, S., Iwata, N., & Saido, T. C. (2014) · Nature Neuroscience · doi:10.1038/nn.3697 · Cited by 1,366
Self-citationWang, E.-S., Yao, H.-B., Chen, Y.-H., Wang, G., Gao, W.-W., Sun, Y.-R., Guo, J.-G., Hu, J.-W., Jiang, C.-C., & Hu, J. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350082 · Cited by 1,176
Luk, K. C., Kehm, V. M., Zhang, B., O’Brien, P., Trojanowski, J. Q., & Lee, V. M. Y. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20112457 · Cited by 1,100
Parkinson's disease: a dual‐hit hypothesis
Hawkes, C. H., Del Tredici, K., & Braak, H. (2007) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2007.00874.x · Cited by 1,021 · cited 1×
“Accumulating evidence suggesting that α-syn pathology can spread from the brain to the periphery or from the gut to the brain has provided support for the ‘dual hit’ hypothesis in PD [17].”
ResultFrequency of Bowel Movements and the Future Risk of Parkinson’s Disease
Abbott, R. D., Petrovitch, H., White, L. R., Masaki, K. H., Tanner, C. M., Curb, J. D., Grandinetti, A., Blanchette, P. L., Popper, J. S., & Ross, G. W. (2001) · Neurology · doi:10.1212/wnl.57.3.456 · Cited by 839 · cited 1×
“The existence of a gut to brain route is strongly supported by early gastrointestinal symptoms which appear many years prior to neurodegeneration [22, 23].”
BackgroundBrain-first versus body-first Parkinson’s disease: a multimodal imaging case-control study
Horsager, J., Andersen, K. B., Knudsen, K., Skjærbæk, C., Fedorova, T. D., Okkels, N., Schaeffer, E., Bonkat, S. K., Geday, J., Otto, M., et al. (2020) · Brain · doi:10.1093/brain/awaa238 · Cited by 782
El‐Agnaf, O. M. A., Salem, S. A., Paleologou, K. E., Curran, M. D., Gibson, M. J., Court, J. A., Schlossmacher, M. G., & Allsop, D. (2006) · The FASEB Journal · doi:10.1096/fj.03-1449com · Cited by 715
Kahle, P. J., Neumann, M., Ozmen, L., Müller, V., Jacobsen, H., Schindzielorz, A., Okochi, M., Leimer, U., van der Putten, H., Probst, A., et al. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-17-06365.2000 · Cited by 641 · cited 4×
“These findings are consistent with the α-syn aggregation-dependent inflammation observed in the brains of the A30P mice and in PD patients [34].”
BackgroundResultInfluentialRed Blood Cells Are the Major Source of Alpha-Synuclein in Blood
Barbour, R., Kling, K., Anderson, J. P., Banducci, K., Cole, T., Diep, L., Fox, M., Goldstein, J. M., Soriano, F., Seubert, P., et al. (2008) · Neurodegenerative Diseases · doi:10.1159/000112832 · Cited by 527 · cited 1×
“Indeed, the red blood cells have been identified to carry α-syn in the blood stream [71].”
BackgroundDetection of elevated levels of α-synuclein oligomers in CSF from patients with Parkinson disease
Tokuda, T., Qureshi, M. M., Ardah, M. T., Varghese, S., Shehab, S. A. S., Kasai, T., Ishigami, N., Tamaoka, A., Nakagawa, M., & El-Agnaf, O. M. A. (2010) · Neurology · doi:10.1212/wnl.0b013e3181fd613b · Cited by 527
Rockenstein, E., Mallory, M., Hashimoto, M., Song, D., Shults, C. W., Lang, I., & Masliah, E. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10231 · Cited by 502 · cited 10×
“Intriguingly, accumulation of α-syn was more extensive in the A30P PD model [4] followed by L61 [2] and lastly the MSA model [1] (Additional file 12: Table III).”
BackgroundInfluentialKiely, A. P., Asi, Y. T., Kara, E., Limousin, P., Ling, H., Lewis, P., Proukakis, C., Quinn, N., Lees, A. J., Hardy, J., et al. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1096-7 · Cited by 451
Medical records documentation of constipation preceding Parkinson disease: A case-control study
Savica, R., Carlin, J. M., Grossardt, B. R., Bower, J. H., Ahlskog, J. E., Maraganore, D. M., Bharucha, A. E., & Rocca, W. A. (2009) · Neurology · doi:10.1212/wnl.0b013e3181c34af5 · Cited by 430
Oueslati, A. (2016) · Journal of Parkinson’s Disease · doi:10.3233/jpd-160779 · Cited by 375 · cited 1×
“We next investigated whether the presence of α-syn within the aged liver is phosphorylated at serine 129 (pS129), a pathological hallmark associated with PD [54].”
BackgroundÅslund, A., Sigurdson, C. J., Klingstedt, T., Grathwohl, S., Bolmont, T., Dickstein, D. L., Glimsdal, E., Prokop, S., Lindgren, M., Konradsson, P., et al. (2009) · ACS Chemical Biology · doi:10.1021/cb900112v · Cited by 331 · cited 1×
“LCO staining p-FTAA and HS-68 were synthesized as described previously [38, 49] and tissue staining was performed as previously reported with slight modifications [37].”
MethodSelf-citationUemura, N., Yagi, H., Uemura, M. T., Hatanaka, Y., Yamakado, H., & Takahashi, R. (2018) · Molecular Neurodegeneration · doi:10.1186/s13024-018-0257-5 · Cited by 328 · cited 1×
“In animal models, recent studies have shown that injection of α-syn within the gut leads to α-syn accumulation in the brain [26].”
BackgroundAlpha‐Synuclein as a Biomarker for Parkinson's Disease
Atik, A., Stewart, T., & Zhang, J. (2016) · Brain Pathology · doi:10.1111/bpa.12370 · Cited by 311 · cited 1×
“Indeed, several studies have now identified α-syn accumulation within the retina, skin, heart, gastrointestinal region, appendix and colon (for review see [9, 10]).”
BackgroundVan Den Berge, N., Ferreira, N., Gram, H., Mikkelsen, T. W., Alstrup, A. K. O., Casadei, N., Tsung-Pin, P., Riess, O., Nyengaard, J. R., Tamgüney, G., et al. (2019) · Acta Neuropathologica · doi:10.1007/s00401-019-02040-w · Cited by 300 · cited 1×
“However, a bidirectional spread of pathology has also been reported [29, 30].”
BackgroundKuo, Y.-M., Li, Z., Jiao, Y., Gaborit, N., Pani, A. K., Orrison, B. M., Bruneau, B. G., Giasson, B. I., Smeyne, R. J., Gershon, M. D., et al. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq038 · Cited by 286 · cited 1×
“they recapitulate the early gastrointestinal abnormalities observed in PD patients prior to neurodegeneration [65].”
BackgroundAlpha‐synuclein transfers from neurons to oligodendrocytes
Reyes, J. F., Rey, N. L., Bousset, L., Melki, R., Brundin, P., & Angot, E. (2014) · Glia · doi:10.1002/glia.22611 · Cited by 281 · cited 7×
“Immunocytochemistry and immunohistochemistry Primary and HuH-7 hepatocytes were processed for immunocytochemistry or immunohistochemistry as previously reported [42].”
BackgroundMethodResultSelf-citationThe vermiform appendix impacts the risk of developing Parkinson’s disease
Killinger, B. A., Madaj, Z., Sikora, J. W., Rey, N., Haas, A. J., Vepa, Y., Lindqvist, D., Chen, H., Thomas, P. M., Brundin, P., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aar5280 · Cited by 279 · cited 1×
“A recent study also suggests that removal of the appendix can reduce PD risk and delay the age of symptom onset [24], although other studies have reported no such association [25].”
ResultTransfer of human α-synuclein from the olfactory bulb to interconnected brain regions in mice
Rey, N. L., Petit, G. H., Bousset, L., Melki, R., & Brundin, P. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1160-3 · Cited by 267
Shults, C. W., Rockenstein, E., Crews, L., Adame, A., Mante, M., Larrea, G., Hashimoto, M., Song, D., Iwatsubo, T., Tsuboi, K., et al. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.3527-05.2005 · Cited by 254 · cited 15×
“Identification of human α‑syn deposits within the MBP29 liver modeling MSA.”
BackgroundMethodInfluentialLázaro, D. F., Rodrigues, E. F., Langohr, R., Shahpasandzadeh, H., Ribeiro, T., Guerreiro, P., Gerhardt, E., Kröhnert, K., Klucken, J., Pereira, M. D., et al. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004741 · Cited by 252 · cited 2×
“While A53T, E46K and H50Q promote higher rates of α-syn aggregation, the A30P mutation appears to cause a slower fibrillar formation rate which thereby promotes oligomer formation [66].”
BackgroundRey, N. L., George, S., Steiner, J. A., Madaj, Z., Luk, K. C., Trojanowski, J. Q., Lee, V. M.-Y., & Brundin, P. (2018) · Acta Neuropathologica · doi:10.1007/s00401-017-1792-9 · Cited by 215
Alpha synuclein is transported into and out of the brain by the blood-brain barrier
Sui, Y.-T., Bullock, K. M., Erickson, M. A., Zhang, J., & Banks, W. A. (2014) · Peptides · doi:10.1016/j.peptides.2014.09.018 · Cited by 212
Autosomal dominant Parkinson's disease caused by SNCA duplications
Konno, T., Ross, O. A., Puschmann, A., Dickson, D. W., & Wszolek, Z. K. (2016) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2015.09.007 · Cited by 210
Bidirectional gut-to-brain and brain-to-gut propagation of synucleinopathy in non-human primates
Arotcarena, M.-L., Dovero, S., Prigent, A., Bourdenx, M., Camus, S., Porras, G., Thiolat, M.-L., Tasselli, M., Aubert, P., Kruse, N., et al. (2020) · Brain · doi:10.1093/brain/awaa096 · Cited by 210
Cognitive decline correlates with neuropathological stage in Parkinson's disease
Braak, H., Rüb, U., & Del Tredici, K. (2006) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2006.05.011 · Cited by 209 · cited 2×
“Intriguingly, accumulation of α-syn was more extensive in the A30P PD model [4] followed by L61 [2] and lastly the MSA model [1] (Additional file 12: Table III).”
BackgroundTong, J., Wong, H., Guttman, M., Ang, L. C., Forno, L. S., Shimadzu, M., Rajput, A. H., Muenter, M. D., Kish, S. J., Hornykiewicz, O., et al. (2010) · Brain · doi:10.1093/brain/awp282 · Cited by 206 · cited 2×
“In our recent work, we identified the gap junction protein connexin-32 (Cx32) centrally involved in the uptake and propagation of α-syn oligomers (oα-syn) in neurons and oligodendrocytes [31], the primary cell types affected by α-syn aggregation in PD and MSA, respectively [5, 32].”
BackgroundClinical overview of the synucleinopathies
Mart�, M. J., Tolosa, E., & Campdelacreu, J. (2003) · Movement Disorders · doi:10.1002/mds.10559 · Cited by 203
Clinical Features of Parkinson’s Disease: The Evolution of Critical Symptoms
Váradi, C. (2020) · Biology · doi:10.3390/biology9050103 · Cited by 196 · cited 1×
“While the clinical manifestations of MSA and DLB are highly variable among patients [2], PD is typically characterized by a progressive decline of motor and non-motor functions which correlate with disease progression [3, 4].”
BackgroundKlingstedt, T., Åslund, A., Simon, R. A., Johansson, L. B. G., Mason, J. J., Nyström, S., Hammarström, P., & Nilsson, K. P. R. (2011) · Organic & Biomolecular Chemistry · doi:10.1039/c1ob05637a · Cited by 193
Self-citationGenetics of Parkinsonʼs disease
Gasser, T. (2005) · Current Opinion in Neurology · doi:10.1097/01.wco.0000170951.08924.3d · Cited by 192
Brain-to-stomach transfer of α-synuclein via vagal preganglionic projections
Ulusoy, A., Phillips, R. J., Helwig, M., Klinkenberg, M., Powley, T. L., & Di Monte, D. A. (2017) · Acta Neuropathologica · doi:10.1007/s00401-016-1661-y · Cited by 179 · cited 1×
“Midbrain overexpression of human α-syn was also demonstrated to reach the gastric wall where it can accumulate into preganglionic vagal terminals [21].”
BackgroundPrion-like Mechanisms in the Pathogenesis of Tauopathies and Synucleinopathies
Goedert, M., Falcon, B., Clavaguera, F., & Tolnay, M. (2014) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-014-0495-z · Cited by 164 · cited 2×
“Intriguingly, accumulation of α-syn was more extensive in the A30P PD model [4] followed by L61 [2] and lastly the MSA model [1] (Additional file 12: Table III).”
BackgroundMultiple system atrophy: a clinical and neuropathological perspective
Ubhi, K., Low, P., & Masliah, E. (2011) · Trends in Neurosciences · doi:10.1016/j.tins.2011.08.003 · Cited by 163 · cited 1×
“In our recent work, we identified the gap junction protein connexin-32 (Cx32) centrally involved in the uptake and propagation of α-syn oligomers (oα-syn) in neurons and oligodendrocytes [31], the primary cell types affected by α-syn aggregation in PD and MSA, respectively [5, 32].”
BackgroundHomozygous alpha-synuclein p.A53V in familial Parkinson's disease
Yoshino, H., Hirano, M., Stoessl, A. J., Imamichi, Y., Ikeda, A., Li, Y., Funayama, M., Yamada, I., Nakamura, Y., Sossi, V., et al. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.05.022 · Cited by 154 · cited 1×
“Currently five SNCA mutations have been described to cause early onset forms of PD (A30P, E46K, H50Q, G51D, and A53E/G/T/V) [66, 67].”
BackgroundPhenotypic spectrum of alpha-synuclein mutations: New insights from patients and cellular models
Petrucci, S., Ginevrino, M., & Valente, E. M. (2015) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2015.08.015 · Cited by 128
Klingstedt, T., Shirani, H., Åslund, A., Cairns, N. J., Sigurdson, C. J., Goedert, M., & Nilsson, K. P. R. (2013) · Chemistry - A European Journal · doi:10.1002/chem.201301463 · Cited by 125 · cited 1×
“LCO staining p-FTAA and HS-68 were synthesized as described previously [38, 49] and tissue staining was performed as previously reported with slight modifications [37].”
MethodSelf-citationKiely, A. P., Ling, H., Asi, Y. T., Kara, E., Proukakis, C., Schapira, A. H., Morris, H. R., Roberts, H. C., Lubbe, S., Limousin, P., et al. (2015) · Molecular Neurodegeneration · doi:10.1186/s13024-015-0038-3 · Cited by 124 · cited 15×
“Intriguingly, accumulation of α-syn was more extensive in the A30P PD model [4] followed by L61 [2] and lastly the MSA model [1] (Additional file 12: Table III).”
BackgroundInfluentialWang, L., Magen, I., Yuan, P. ‐., Subramaniam, S. R., Richter, F., Chesselet, M. ‐., & Taché, Y. (2012) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2012.01974.x · Cited by 114 · cited 1×
“Moreover, these mice have been demonstrated to have alterations in the colonic myenteric ganglia thus showing deficits in defecation [64].”
BackgroundRey, N. L., Bousset, L., George, S., Madaj, Z., Meyerdirk, L., Schulz, E., Steiner, J. A., Melki, R., & Brundin, P. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0859-3 · Cited by 114
Alpha-synuclein overexpressing transgenic mice show internal organ pathology and autonomic deficits
Hallett, P. J., McLean, J. R., Kartunen, A., Langston, J. W., & Isacson, O. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.04.009 · Cited by 110 · cited 1×
“Morphologically and compared to littermate controls, the L61 model appears to develop swollen and pallor intestines as well as large urinary bladders, particularly in aged mice (12–15 months) [63].”
BackgroundHammarström, P., Simon, R. A., Nyström, S., Konradsson, P., Åslund, A., & Nilsson, K. P. R. (2010) · Biochemistry · doi:10.1021/bi100922r · Cited by 105
Self-citationA possible link between astrocyte activation and tau nitration in Alzheimer's disease
Reyes, J. F., Reynolds, M. R., Horowitz, P. M., Fu, Y., Guillozet-Bongaarts, A. L., Berry, R., & Binder, L. I. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.04.005 · Cited by 88
Self-citationα-Synuclein Is Expressed in Different Tissues During Human Fetal Development
Baltic, S., Perović, M., Mladenović, A., Zogovic, N. S., Ruždijić, S., Rakić, L., & Kanazir, S. (2004) · Journal of Molecular Neuroscience · doi:10.1385/jmn:22:3:199 · Cited by 88 · cited 3×
“In humans, Ltic and colleagues reported a decrease in the presence of α-syn within peripheral tissues which correlated with cellular maturation, thus showing no expression of α-syn in adult liver samples [73].”
BackgroundInfluentialAlpha-Synuclein in Peripheral Tissues in Parkinson’s Disease
Ma, L., Liu, G.-L., Wang, D., Zhang, M., Kou, W., & Feng, T. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00383 · Cited by 87 · cited 3×
“Indeed, α-syn protein deposition has been identified in multiple organs outside the CNS in patients with PD (reviewed in [9]).”
BackgroundPeripheral Synucleinopathy in Early Parkinson's Disease: Submandibular Gland Needle Biopsy Findings
Adler, C. H., Dugger, B. N., Hentz, J. G., Hinni, M. L., Lott, D. G., Driver‐Dunckley, E., Mehta, S., Serrano, G., Sue, L. I., Duffy, A., et al. (2016) · Movement Disorders · doi:10.1002/mds.26476 · Cited by 85 · cited 1×
“Accumulating evidence now demonstrates that the distribution of α-syn pathology is not limited to the brain but also extends to the peripheral autonomic neuronal network [9, 62].”
BackgroundReyes, J. F., Sackmann, C., Hoffmann, A., Svenningsson, P., Winkler, J., Ingelsson, M., & Hallbeck, M. (2019) · Acta Neuropathologica · doi:10.1007/s00401-019-02007-x · Cited by 73 · cited 8×
“In our recent work, we identified the gap junction protein connexin-32 (Cx32) centrally involved in the uptake and propagation of α-syn oligomers (oα-syn) in neurons and oligodendrocytes [31], the primary cell types affected by α-syn aggregation in PD and MSA, respectively [5, 32].”
BackgroundMethodResultSelf-citationIncreased alpha-synuclein tear fluid levels in patients with Parkinson’s disease
Maass, F., Rikker, S., Dambeck, V., Arias, C. C. W. P., Tatenhorst, L., Csóti, I., Schmitz, M., Zerr, I., Leha, A., Bähr, M., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-65503-1 · Cited by 73
Genetically engineered mouse models of Parkinson's disease
Crabtree, D. M., & Zhang, J. (2012) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2011.07.019 · Cited by 70 · cited 2×
“Thus, the accumulation of liver α-syn appears to correlate with the amount of α-syn deposition within the brain of these synucleinopathy models [60].”
BackgroundConnexin and pannexin (hemi)channels in the liver
Maes, M., Decrock, E., Cogliati, B., de Oliveira, A. G., Marques, P. E., Dagli, M. L., Menezes, G. B., Mennecier, G., Leybaert, L., Vanhaecke, T., et al. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2013.00405 · Cited by 70 · cited 2×
“Consistent with previous results [31], we demonstrate a protein–protein interaction between oα-syn and Cx32 in human hepatocytes, the main cell type within the liver and the main organ responsible for substance clearance and detoxification in the body [33].”
BackgroundResultTyrosine Nitration within the Proline-Rich Region of Tau in Alzheimer's Disease
Reyes, J. F., Fu, Y., Vana, L., Kanaan, N. M., & Binder, L. I. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.01.030 · Cited by 64
Self-citationKlingstedt, T., Shirani, H., Mahler, J., Wegenast‐Braun, B. M., Nyström, S., Goedert, M., Jucker, M., & Nilsson, K. P. R. (2015) · Chemistry - A European Journal · doi:10.1002/chem.201500556 · Cited by 62 · cited 1×
“A similar spectral signature was previously reported for immature amyloid beta (Aß) and tau aggregates in brains of young transgenic AD mice and might therefore be indicative of less mature assemblies [55, 56].”
BackgroundSelf-citationKlingstedt, T., Blechschmidt, C., Nogalska, A., Prokop, S., Häggqvist, B., Danielsson, O., Engel, W. K., Askanas, V., Heppner, F. L., & Nilsson, K. P. R. (2013) · ChemBioChem · doi:10.1002/cbic.201200731 · Cited by 60
Self-citationA novel panel of α-synuclein antibodies reveal distinctive staining profiles in synucleinopathies
Dhillon, J.-K. S., Riffe, C., Moore, B. D., Ran, Y., Chakrabarty, P., Golde, T. E., & Giasson, B. I. (2017) · PLOS ONE · doi:10.1371/journal.pone.0184731 · Cited by 57 · cited 1×
“mice To further characterize the identity and accumulation of human α-syn within the liver of the A30P model, we performed immunohistochemistry on aged liver tissue sections using the widely used human specific α-syn clone Syn-211 (211) antibody which recognizes α-syn pathology in PD brain [53].”
MethodKlingstedt, T., & Nilsson, K. P. R. (2012) · Biochemical Society Transactions · doi:10.1042/bst20120009 · Cited by 54 · cited 2×
“A similar spectral signature was previously reported for immature amyloid beta (Aß) and tau aggregates in brains of young transgenic AD mice and might therefore be indicative of less mature assemblies [55, 56].”
BackgroundMethodSelf-citationKlingstedt, T., Ghetti, B. F., Holton, J. L., Ling, H., Nilsson, K. P. R., & Goedert, M. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0840-1 · Cited by 52 · cited 2×
“LCO staining p-FTAA and HS-68 were synthesized as described previously [38, 49] and tissue staining was performed as previously reported with slight modifications [37].”
MethodResultSelf-citationHamm‐Alvarez, S. F., Janga, S. R., Edman, M. C., Feigenbaum, D., Freire, D., Mack, W. J., Okamoto, C. T., & Lew, M. (2019) · Biomarkers in Medicine · doi:10.2217/bmm-2019-0315 · Cited by 50
α‐Synuclein in blood cells differentiates Parkinson’s disease from healthy controls
Elhadi, S. A., Grigoletto, J., Poli, M., Arosio, P., Arkadir, D., & Sharon, R. (2019) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.50944 · Cited by 50
Selective tau tyrosine nitration in non-AD tauopathies
Reyes, J. F., Geula, C., Vana, L., & Binder, L. I. (2012) · Acta Neuropathologica · doi:10.1007/s00401-011-0898-8 · Cited by 46
Self-citationAppendectomy and risk of Parkinson's disease in two large prospective cohorts of men and women
Palacios, N., Hughes, K. C., Cereda, E., Schwarzschild, M. A., & Ascherio, A. (2018) · Movement Disorders · doi:10.1002/mds.109 · Cited by 46 · cited 1×
“A recent study also suggests that removal of the appendix can reduce PD risk and delay the age of symptom onset [24], although other studies have reported no such association [25].”
ResultEarly fine motor impairment and behavioral dysfunction in (Thy‐1)‐h[A30P] alpha‐synuclein mice
Ekmark‐Lewén, S., Lindström, V., Gumucio, A., Ihse, E., Behere, A., Kahle, P. J., Nordström, E. K. L., Eriksson, M., Erlandsson, A., Bergström, J. J. E., et al. (2018) · Brain and Behavior · doi:10.1002/brb3.915 · Cited by 42 · cited 9×
“Intriguingly, accumulation of α-syn was more extensive in the A30P PD model [4] followed by L61 [2] and lastly the MSA model [1] (Additional file 12: Table III).”
MethodSelf-citationHepatic nervous system and neurobiology of the liver
Jensen, K. J., Alpini, G., & Glaser, S. (2013) · Comprehensive physiology · doi:10.1002/j.2040-4603.2013.tb00506.x · Cited by 38 · cited 1×
“Indeed, branches of both the vagal and splanchnic nerves directly innervate the liver via the portal area, and these connections are associated with the portal vein and bile ducts (for review please see [70]).”
BackgroundSung, J. Y., Lee, H. J., Jeong, E. I., Oh, Y., Park, J., Kang, K., & Chung, K. C. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2007.02.025 · Cited by 37
Total α-synuclein levels in human blood cells, CSF, and saliva determined by a lipid-ELISA
Elhadi, S. A., Basora, M., Vilas, D., TOLOSA, E. S., & Sharon, R. (2016) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-016-9863-7 · Cited by 30
Stockert, R. J., Spray, D. C., Gao, Y., Suadicani, S. O., Ripley, C. R., Novikoff, P. M., Wolkoff, A. W., & Hertzberg, E. L. (1999) · Hepatology · doi:10.1002/hep.510300304 · Cited by 22 · cited 1×
“To further demonstrate a Cx32/α-syn protein interaction, we stably overexpressed Cx32-mCherry in the widely used human hepatocyte cell line HuH-7, a cell type that normally lacks Cx32 expression [51].”
MethodTransmission of Tau Pathology Induced by Synthetic Preformed Tau Filaments
Reyes, J. F., Rey, N. L., & Angot, É. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.0725-13.2013 · Cited by 12 · cited 1×
“Following protein assembly validation, we incubated oα-syn and non-sonicated fibrillar assemblies (to avoid oligomer formation [50]) with primary human hepatocytes isolated from five healthy adult human livers for 24 h.”
MethodSelf-citationTank, J., Gonçalves, A. C. D. C., Kamer, I., Qadri, F., Ubhi, K. K., Rockenstein, E. M., Diedrich, A., Masliah, E., Groß, V., & Jordan, J. (2014) · Physiological Reports · doi:10.14814/phy2.12209 · Cited by 8 · cited 15×
“Identification of human α‑syn deposits within the MBP29 liver modeling MSA.”
BackgroundInfluential(1982) · PubMed
Cited by
Amyloid-type Protein Aggregation and Prion-like Properties of Amyloids
Willbold, D., Strodel, B., Schröder, G. F., Hoyer, W., & Heise, H. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00196 · Cited by 221
Antiageing strategy for neurodegenerative diseases: from mechanisms to clinical advances
Jiang, Q., Liu, J., Huang, S., Wang, X.-Y., Chen, X., Liu, G.-H., Ye, K., Song, W., Masters, C. L., Wang, J., et al. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02145-7 · Cited by 165
“230 In PD, brain-derived α - syn accumulates in the livers of both mice and humans; thus, the liver may participate in the clearance and detoxi fi cation of α -syn, 231 suggesting that a decrease in aged liver function increases α -syn deposition in the brain.”
Propagation of pathologic α-synuclein from kidney to brain may contribute to Parkinson’s disease
Yuan, X., Nie, S., Yang, Y., Liu, C., Xia, D., Meng, L., Xia, Y., Su, H., Zhang, C., Bu, L., et al. (2025) · Nature Neuroscience · doi:10.1038/s41593-024-01866-2 · Cited by 92
Xiang, J., Tang, J., Kang, F., Ye, J., Cui, Y., Zhang, Z., Wang, J., Wu, S., & Ye, K. (2024) · Neuron · doi:10.1016/j.neuron.2024.08.003 · Cited by 90
Alpha-Synuclein Contribution to Neuronal and Glial Damage in Parkinson’s Disease
Saramowicz, K., Siwecka, N., Galita, G., Kucharska-Lusina, A., Rozpędek‐Kamińska, W., & Majsterek, I. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms25010360 · Cited by 87
“These findings not only reinforced the view that PD is a systemic disorder but also pointed to the possibility of using peripheral, readily obtainable α Syn as a potential biomarker of PD [12–14].”
Metadata
- Authors
- Reyes, J. F., Ekmark-Léwen, S., Perdiki, M., Klingstedt, T., Hoffmann, A., Wiechec, E., Nilsson, P., Nilsson, K. P. R., Alafuzoff, I., Ingelsson, M., & Hallbeck, M.
- Affiliations
- Linköping University (SE)
- Friedrich-Alexander-Universität Erlangen-Nürnberg (DE)
- Karolinska Institutet (SE)
- Uppsala University Hospital (SE)
- Uppsala University (SE)
- Corresponding author
- Reyes, Juan F.
- ORCID
- Venue
- Acta Neuropathologica Communications
- Published
- 2021-03-20
- Volume
- 9
- Issue
- 1
- Pages
- 46-46
- ISSN
- 2051-5960 (ISSN-L)
- PMC
- PMC7980682
- OpenAlex
- W3137660980
- Cited by
- 59
- References
- 74
- Citations by year
- 2026: 15 · 2025: 22 · 2024: 9 · 2023: 9 · 2022: 2 · 2021: 2
- FWCI
- 2.63
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor)
- Locations
- Acta Neuropathologica Communications (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DiVA (Linkoping University) (submittedVersion, other-oa)
- KTH Publication Database DiVA (KTH Royal Institute of Technology) (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- OPUS FAU (Kooperativer Bibliotheksverbund Berlin-Brandenburg (KOBV), on behalf of the Universitätsbibliothek Erlangen-Nürnberg) (submittedVersion, cc-by)
- Funders
- Vetenskapsrådet (2019-01016)
- Linköping University
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- alpha-synuclein, Parkinson's disease, synucleinopathies, liver, hepatocytes, connexin 32, gap junctions, protein clearance, transgenic mouse model, amyloid-beta, protein oligomers
- MeSH terms
- Synucleinopathies, Aged, Aged, 80 and over, Animals, Brain, Disease Models, Animal, Female, Humans, Liver, Male, Mice, Transgenic, Parkinson Disease, Lewy Body Disease, Microscopy, Electron, Transmission, Mice, alpha-Synuclein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.